Defiance ETFs has launched the Defiance Autism Impact ETF (NASDAQ:ASD), a first-of-its-kind ETF designed to provide investors with exposure to companies developing products, therapies, services and technologies that support individuals with autism and related neurodevelopmental conditions. • Defiance Autism Impact ETF shares are showing limited movement.
Where is ASD stock headed?
The launch marks the culmination of a strategy first outlined in a March regulatory filing and introduces a rare combination of thematic investing and philanthropy.
The fund arrives as investors continue to show interest in health care innovation themes ranging from AI-powered drug discovery to next-generation therapeutics and medical technologies.
Defiance CEO Matthew Bielski said the fund was inspired by his personal experience raising a profoundly autistic child.
